Literature DB >> 893714

Delinquents and the Tapping Test.

J M Andrew.   

Abstract

This study provided Tapping Test norms for young legal offenders by measuring 54 Anglo male probationers (35 juveniles, 19 adults) in Study I, and 127 probationers aged 12-17 within eight sex/age/ethnicity subgroups in Study II. The Tapping Test, a measure of fine-motor speed, forms part of the Halstead-Reitan battery for neuropsychodiagnosis. Study I results suggest that tapping speed related to age for juvenile male delinquents, p less than .01; for adults, speed relates to IQ, p less than .05. Study II results suggest that Anglo females--but not non-Anglo females-- tap slower than males, p less than .01. The results were only paritally consistent with those of prior studies. Future researchers may wish to: (a) refine norms by appropriate adjustments for age and IQ; (b) investigate why Anglo female delinquents were especially slow on the Tapping Test; and (c) evaluate to what extent false positives may be provoked on this test by depression rather than organicity.

Entities:  

Mesh:

Year:  1977        PMID: 893714     DOI: 10.1002/1097-4679(197707)33:3<786::aid-jclp2270330340>3.0.co;2-x

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  9 in total

1.  Reversal of mecamylamine-induced effects in healthy subjects by nicotine receptor agonists: Cognitive and (electro) physiological responses.

Authors:  Ricardo Alvarez-Jimenez; Ellen P Hart; Samantha Prins; Marieke de Kam; Joop M A van Gerven; Adam F Cohen; Geert Jan Groeneveld
Journal:  Br J Clin Pharmacol       Date:  2018-02-20       Impact factor: 4.335

2.  Are left-handers less violent?

Authors:  J M Andrew
Journal:  J Youth Adolesc       Date:  1980-02

3.  Central nervous system effects of the interaction between risperidone (single dose) and the 5-HT6 antagonist SB742457 (repeated doses) in healthy men.

Authors:  Marieke Liem-Moolenaar; Mandana Rad; Stefano Zamuner; Adam F Cohen; Francesca Lemme; Kari L Franson; Joop M A van Gerven; Emilio Merlo Pich
Journal:  Br J Clin Pharmacol       Date:  2011-06       Impact factor: 4.335

4.  An anti-nicotinic cognitive challenge model using mecamylamine in comparison with the anti-muscarinic cognitive challenge using scopolamine.

Authors:  Anne Catrien Baakman; Ricardo Alvarez-Jimenez; Robert Rissmann; Erica S Klaassen; Jasper Stevens; Sebastiaan C Goulooze; Jeroen C G den Burger; Eleonora L Swart; Joop M A van Gerven; Geert Jan Groeneveld
Journal:  Br J Clin Pharmacol       Date:  2017-04-08       Impact factor: 4.335

5.  Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects.

Authors:  Marieke Liem-Moolenaar; Peter de Boer; Maarten Timmers; Rik C Schoemaker; J G Coen van Hasselt; Stephan Schmidt; Joop M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2011-06       Impact factor: 4.335

6.  No synergistic effect of subtherapeutic doses of donepezil and EVP-6124 in healthy elderly subjects in a scopolamine challenge model.

Authors:  Anne Catrien Baakman; Ricardo Alvarez-Jimenez; Gordon Loewen; Marieke L de Kam; Karen Broekhuizen; Dana C Hilt; Geert Jan Groeneveld
Journal:  Alzheimers Dement (N Y)       Date:  2019-04-01

7.  A cross-sectional study in healthy elderly subjects aimed at development of an algorithm to increase identification of Alzheimer pathology for the purpose of clinical trial participation.

Authors:  Samantha Prins; Ahnjili Zhuparris; Ellen P Hart; Robert-Jan Doll; Geert Jan Groeneveld
Journal:  Alzheimers Res Ther       Date:  2021-07-17       Impact factor: 6.982

8.  Biperiden Challenge Model in Healthy Elderly as Proof-of-Pharmacology Tool: A Randomized, Placebo-Controlled Trial.

Authors:  Charlotte Bakker; Michiel J van Esdonk; Rik F E Stuurman; Laura G J M Borghans; Marieke L de Kam; Joop M A van Gerven; Geert Jan Groeneveld
Journal:  J Clin Pharmacol       Date:  2021-07-29       Impact factor: 3.126

9.  Safety, pharmacokinetics and pharmacodynamics of SBT-020 in patients with early stage Huntington's disease, a 2-part study.

Authors:  Marcus P J van Diemen; Ellen P Hart; Anthony Abbruscato; Liz Mead; Ilse van Beelen; Sandrin C Bergheanu; Pieter W Hameeteman; Emma Coppen; Jessica Y Winder; Matthijs Moerland; Hermien Kan; Jeroen van der Grond; Andrew Webb; Raymund A C Roos; Geert Jan Groeneveld
Journal:  Br J Clin Pharmacol       Date:  2020-12-29       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.